9/10/2026
FDA outlines new psychedelic drug framework in NEJM
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
Topic archive
2 stories
9/10/2026
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
8/18/2026
April order seeks to fast-track therapies for serious conditions.